- Home
- TACT vs CLNN Comparison
TACT vs CLNN Comparison
Compare TACT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- CLNN
- Stock Information
- Founded
- TACT 1996
- CLNN 2012
- Country
- TACT United States
- CLNN United States
- Employees
- TACT N/A
- CLNN N/A
- Industry
- TACT Computer peripheral equipment
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- CLNN Health Care
- Exchange
- TACT Nasdaq
- CLNN Nasdaq
- Market Cap
- TACT 51.0M
- CLNN 60.3M
- IPO Year
- TACT 1996
- CLNN N/A
- Fundamental
- Price
- TACT $5.42
- CLNN $8.92
- Analyst Decision
- TACT Strong Buy
- CLNN Strong Buy
- Analyst Count
- TACT 1
- CLNN 6
- Target Price
- TACT $5.00
- CLNN $32.67
- AVG Volume (30 Days)
- TACT 69.2K
- CLNN 149.4K
- Earning Date
- TACT 11-06-2025
- CLNN 11-12-2025
- Dividend Yield
- TACT N/A
- CLNN N/A
- EPS Growth
- TACT N/A
- CLNN N/A
- EPS
- TACT N/A
- CLNN N/A
- Revenue
- TACT $47,949,000.00
- CLNN $286,000.00
- Revenue This Year
- TACT $21.67
- CLNN N/A
- Revenue Next Year
- TACT $7.63
- CLNN $1,363.77
- P/E Ratio
- TACT N/A
- CLNN N/A
- Revenue Growth
- TACT N/A
- CLNN N/A
- 52 Week Low
- TACT $3.12
- CLNN $2.28
- 52 Week High
- TACT $5.70
- CLNN $11.06
- Technical
- Relative Strength Index (RSI)
- TACT 63.38
- CLNN 64.53
- Support Level
- TACT $5.05
- CLNN $5.62
- Resistance Level
- TACT $5.70
- CLNN $11.00
- Average True Range (ATR)
- TACT 0.26
- CLNN 0.86
- MACD
- TACT -0.00
- CLNN 0.33
- Stochastic Oscillator
- TACT 74.59
- CLNN 58.55
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.